Covered recipient · General Payments record
KATHRYN MCKENNA-WEISS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$688.80
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $360.13 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $149.33 | 8 |
| Indivior Inc. | $57.20 | 2 |
| Braeburn Inc. | $53.38 | 2 |
| ABBVIE INC. | $50.83 | 2 |
| Alkermes, Inc. | $30.93 | 2 |
| Orexo US, Inc. | $18.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.54 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635650 | CMS |
| ABBVIE INC. | $32.29 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635652 | CMS |
| Alkermes, Inc. | $17.37 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120551758 | CMS |
| Alkermes, Inc. | $13.56 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120551760 | CMS |
| Braeburn Inc. | $27.02 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125616258 | CMS |
| Braeburn Inc. | $26.36 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125616260 | CMS |
| Gilead Sciences, Inc. | $22.40 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133665476 | CMS |
| Gilead Sciences, Inc. | $30.29 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133665478 | CMS |
| Gilead Sciences, Inc. | $5.95 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133665480 | CMS |
| Gilead Sciences, Inc. | $20.79 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133665482 | CMS |
| Gilead Sciences, Inc. | $17.74 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133665484 | CMS |
| Gilead Sciences, Inc. | $25.36 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133665486 | CMS |
| Gilead Sciences, Inc. | $7.08 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133665488 | CMS |
| Gilead Sciences, Inc. | $19.72 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133665490 | CMS |
| Indivior Inc. | $26.19 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144562713 | CMS |
| Indivior Inc. | $31.01 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144562715 | CMS |
| Orexo US, Inc. | $18.46 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136177792 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.